Rare diseases
Investigational molecules
Locations
111 Speen Street Suite 306, 01701-2090, United States
Alzheon Inc. focuses on clinical research in Alzheimer's disease among APOE4 carriers, particularly individuals with APOE4/4 and APOE3/4 genotypes who are in the early stage of disease. The research interest centers on patients aged 50 to 80 years with clinically diagnosed Alzheimer's disease.
The sponsor’s clinical activity is concentrated in North America and involves collaboration across multiple research sites, with active work extending across two countries.
Alzheon Inc. runs clinical trials in conditions such as Dementia Alzheimer's type, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
CzechiaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
